• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.


  1. SWAlexander

    Role of pharmacological activity of autoantibodies in ME/CFS

    Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a condition characterised by extreme fatigue, memory impairment, pain and other symptoms that vary from patient to patient. It affects about 0.9% of the population and is often triggered by an acute...
  2. SWAlexander

    As a severely affected #MECFS patient, I was saved by people who didn't duck away

    because there is no routine care for ME/CFS in the system, but felt "in charge" of me as a person and were willing to give treatment that made sense in my case to make it possible for me - against immense hurdles! Doctors and a therapist who not only helped me to get therapies but also carried...
  3. Murph

    Immunoadsorption to remove ß2 adrenergic receptor antibodies in CFS/ME.

    PLoS One. 2018 Mar 15;13(3):e0193672. doi: 10.1371/journal.pone.0193672. eCollection 2018. Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. Scheibenbogen C1,2, Loebel M1, Freitag H1, Krueger A3, Bauer S1, Antelmann M1, Doehner W4, Scherbakov N4...